KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,297,000 | +125.5% | 263,584 | +45.3% | 0.27% | +130.3% |
| Q2 2017 | $3,236,000 | +37.4% | 181,349 | +18.3% | 0.12% | +21.4% |
| Q1 2017 | $2,355,000 | +615.8% | 153,263 | +53.3% | 0.10% | +716.7% |
| Q4 2016 | $329,000 | -69.1% | 99,966 | -49.9% | 0.01% | -75.0% |
| Q3 2016 | $1,064,000 | +66.0% | 199,678 | +209.2% | 0.05% | +45.5% |
| Q2 2016 | $641,000 | +0.9% | 64,578 | -32.4% | 0.03% | -21.4% |
| Q1 2016 | $635,000 | -39.4% | 95,478 | -15.0% | 0.04% | -27.6% |
| Q4 2015 | $1,047,000 | – | 112,379 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |